N
Naoto T. Ueno
Researcher at University of Texas MD Anderson Cancer Center
Publications - 390
Citations - 13778
Naoto T. Ueno is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Inflammatory breast cancer. The author has an hindex of 59, co-authored 389 publications receiving 11623 citations. Previous affiliations of Naoto T. Ueno include University of Texas Health Science Center at Houston & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
A Brief Review of the Biophysical Hallmarks of Metastatic Cancer Cells.
TL;DR: The importance of the biophysical features of cancer cells in tumor metastasis are defined and the state-of-the-art technology for the study of cell biomechanics is summarized.
Journal ArticleDOI
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center.
Paolo Anderlini,Rima M. Saliba,Sandra Acholonu,Grace Julia Okoroji,Celina Ledesma,Borje S. Andersson,Roy B. Jones,Uday R. Popat,Chitra Hosing,Yago Nieto,Muzaffar H. Qazilbash,Naoto T. Ueno,Sergio Giralt,Marcos de Lima,Richard E. Champlin +14 more
TL;DR: It is felt that the designation “donor leukocyte infusion” is preferable to ‘donor lymphocytes infusion’, as clearly the infused product contains additional cell types in addition to lymphocytes, such as monocytes, natural killer (NK) cells, etc.
Journal ArticleDOI
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
Xiaoding Hu,Emilly S. Villodre,Richard A. Larson,Omar M. Rahal,Xiaoping Wang,Yun Gong,Juhee Song,Savitri Krishnamurthy,Naoto T. Ueno,Debu Tripathy,Wendy A. Woodward,Bisrat G. Debeb +11 more
TL;DR: Hu et al. as mentioned in this paper showed that decorin, a small leucine-rich extracellular matrix proteoglycan, is downregulated in tumors from patients with inflammatory breast cancer.
Journal ArticleDOI
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
Takahiro Kogawa,Tamer M. Fouad,Caimiao Wei,Hiroko Masuda,Kazuharu Kai,Takeo Fujii,Randa El-Zein,Mariana Chavez-MacGregor,Jennifer K. Litton,Abenaa M. Brewster,Ricardo H. Alvarez,Gabriel N. Hortobagyi,Vicente Valero,Richard L. Theriault,Naoto T. Ueno +14 more
TL;DR: The results show that increasing BMI shows improved clinical outcome in terms of better pCR rates in normal BMI/underweight group and in the postmenopausal group, and contradict previously reported findings on the association between high BMI and poor clinical efficacy regarding pCR rate and survival outcomes in early-stage breast cancer.
Journal ArticleDOI
Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: A CIBMTR retrospective analysis
Rachel J Cook,Zhiwei Wang,Mukta Arora,Hillard M. Lazarus,Kimberly A. Kasow,Martin A. Champagne,Wael Saber,K. van Besien,Gregory A. Hale,Edward A. Copelan,M. Elmongy,Naoto T. Ueno,Biljana Horn,Shimon Slavin,Michael R. Bishop,Edward A. Stadtmauer +15 more
TL;DR: Auto-SCT is a tolerable approach in patients with DSRCTP, with the greatest benefit seen in those patients who obtain CR, and for those not in CR, the median OS in this series is greater than previously reported (21 months vs 17 months), suggesting Auto-S CT is useful in prolonging DFS and OS, even in Patients with residual or persistent disease pre-transplant.